Login | New Member? Signup Free
ChangeDetect » News

Pfizer’s slams India’s patent regime, says Indian standards are vague and malleable

American drugmaker Pfizer Inc has slammed the patent regime in India, telling a domestic industry body in a letter that all patents that the company has managed to get in the country do not have any meaning.

Tags: , , , , , ,

Pfizer, Samsung, Microsoft, Wipo: Intellectual Property

Pfizer Inc. won a ruling that blocks generic versions of its drug Lyrica until 2018. U.S. District Judge Gregory M. Sleet ruled yesterday that Teva Pharmaceutical Industries Ltd. and other generic-drug makers infringed some claims of patents covering Lyrica.

Tags: , , , , , , , , , , , ,

Pfizer, Samsung, Microsoft, Wipo: Intellectual Property

Pfizer Inc. won a ruling that blocks generic versions of its drug Lyrica until 2018. U.S. District Judge Gregory M. Sleet ruled yesterday that Teva Pharmaceutical Industries Ltd. and other generic-drug makers infringed some claims of patents covering Lyrica.

Tags: , , , , , , , , , , , ,

US retailers sue Pfizer over generic Lipitor delay

Five large US drug and grocery chains are suing Pfizer Inc and a second drugmaker, alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor.

Tags: , , , , , , , ,

Pfizer, Research Affiliates, Occupy?: Intellectual Property

Pfizer Inc. s Wyeth unit and Teva Pharmaceuticals USA Inc. were accused by a group of prescription drug retailers of illegally keeping a generic version of the Effexor XR antidepressant off the market.

Tags: , , , , , , , , , , ,

Pfizer wins extension of Lipitor patent

WASHINGTON – Pfizer Inc. won new protection on the cholesterol pill Lipitor, the world’s best-selling drug, after the United States agreed to reissue a patent on the drug’s key ingredient that had been invalidated by an appeals court. (2 hours ago)

Terms: lipitor patent extension

Tags: , , , , , , ,

Pfizer ends its cancer vaccine partnership

Pfizer Inc. has backed out of a cancer vaccine program in midstage development, telling partner Celldex Therapeutics Inc. that its strategic priorities have changed.The pharmaceutical giant, with (4 mins ago)

Tags: , , , , , , ,